We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.97B
AUM Growth
+$203M
Cap. Flow
+$159M
Cap. Flow %
8.06%
Top 10 Hldgs %
32.42%
Holding
162
New
22
Increased
42
Reduced
69
Closed
28

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$28M
2
COUR icon
Coursera
COUR
+$20.3M
3
PINC
Premier
PINC
+$18.6M
4
LYFT icon
Lyft
LYFT
+$18.3M
5
PYPL icon
PayPal
PYPL
+$16.9M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$39M
2
DBX icon
Dropbox
DBX
+$30.5M
3
VNT icon
Vontier
VNT
+$24.8M
4
FISV
Fiserv Inc
FISV
+$16.2M
5
FFIV icon
F5
FFIV
+$15.6M

Sector Composition

Rank Sector Weight
1 Technology 26.57%
2 Communication Services 12.72%
3 Healthcare 12.33%
4 Consumer Discretionary 10.59%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BV icon
126
BrightView Holdings
BV
$1.07B
$1.29M 0.07%
179,156
-478,538
-73% -$3.02M
ASTL icon
127
Algoma Steel
ASTL
$431M
$1.24M 0.06%
174,857
-7,501
-4% -$55.7K
ZD icon
128
Ziff Davis
ZD
$1.98B
$1.16M 0.06%
16,609
-1,752
-10% -$120K
PRAA icon
129
PRA Group
PRAA
$755M
$1.16M 0.06%
+50,680
New +$1.4M
PHX
130
DELISTED
PHX Minerals
PHX
$862K 0.04%
276,396
-67,873
-20% -$193K
MAGN
131
Magnera Corp
MAGN
$460M
$823K 0.04%
20,962
-1,822
-8% -$82.6K
CVEO icon
132
Civeo
CVEO
$318M
$741K 0.04%
+38,038
New +$767K
LEXX icon
133
Lexaria Bioscience
LEXX
$8.71M
$560K 0.03%
51,105
+19,565
+62% +$380K
STRT icon
134
STRATTEC Security
STRT
$361M
$301K 0.02%
16,589
-26,661
-62% -$508K
ABEV icon
135
Ambev
ABEV
$46.4B
-734,890
Closed -$2.07M
APP icon
136
CALL
Applovin
APP
$116B
-600,000
Closed -$9.45M
BLCO icon
137
Bausch + Lomb
BLCO
$5.99B
-800,926
Closed -$13.9M
CGNT icon
138
Cognyte Software
CGNT
$680M
-919,102
Closed -$3.12M
CLS icon
139
Celestica
CLS
$36.5B
-753,222
Closed -$9.72M
ELAN icon
140
Elanco Animal Health
ELAN
$11.1B
-1,391,933
Closed -$13.1M
FDX icon
141
FedEx
FDX
$75.4B
-35,468
Closed -$8.1M
FFIV icon
142
F5
FFIV
$22.7B
-106,825
Closed -$15.6M
GSM icon
143
FerroAtlántica
GSM
$839M
-762,239
Closed -$3.77M
HBI
144
DELISTED
Hanesbrands
HBI
-2,750,911
Closed -$14.5M
INFA
145
DELISTED
Informatica
INFA
-275,458
Closed -$4.52M
INTC icon
146
Intel
INTC
$513B
-231,829
Closed -$7.57M
LASR icon
147
nLIGHT
LASR
$3.17B
-419,828
Closed -$4.27M
MDT icon
148
Medtronic
MDT
$112B
-190,306
Closed -$15.3M
META icon
149
Meta Platforms (Facebook)
META
$1.51T
-184,145
Closed -$39M
MUR icon
150
Murphy Oil
MUR
$4.78B
-220,558
Closed -$8.16M

Similar funds

Invenomic Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Invenomic Capital Management held 162 positions worth $1.97B, up 11% from $1.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Invenomic Capital Management deployed $159M of net new capital in Q2 2023, opening 22 new positions and adding to 42 existing holdings. Its largest new stake was Citigroup: 596,817 shares worth $27.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Dropbox, an estimated $30.5M trimmed.

  • Invenomic Capital Management's largest Q2 2023 buy was Citigroup: 596,817 shares worth $27.5M.
  • Invenomic Capital Management added most to Coursera in Q2 2023, an estimated $20.3M increase.
  • Invenomic Capital Management's biggest Q2 2023 reduction was Dropbox, cutting an estimated $30.5M.
  • Invenomic Capital Management fully exited Meta Platforms (Facebook) in Q2 2023, selling an estimated $39M.
  • Invenomic Capital Management's ten largest holdings make up 32% of its $1.97B portfolio in Q2 2023.
  • Invenomic Capital Management opened 22 new positions and closed 28 in Q2 2023.
  • Invenomic Capital Management's portfolio value rose 11% quarter-over-quarter to $1.97B.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.